In non-small-cell lung cancer (NSCLC) patients (12), HLA-F expression was detected in 24.1% (20/83) of NSCLC primary lesions but not in any of the adjacent normal lung tissues. Here, HLA-F is linked to non-small cell lung carcinoma.